William Febbo | CEO |
Doug Baker | CFO |
Miriam Paramore | President |
Andrew D'Silva | B. Riley FBR |
Richard Baldry | ROTH Capital |
Eric Martinuzzi | Lake Street |
Harvey Poppel | PopTech |
Good afternoon, and thank you for joining us today to discuss OptimizeRx Third Quarter ended September 30, 2018. With us today is the Chief Executive Officer of OptimizeRx, William Febbo; he is joined by the company’s President, Miriam Paramore; and its Chief Financial Officer, Doug Baker.
Following their remarks, we'll open your call to questions. Then before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during today's call. I'd also like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release in the investor's section of the company's website.